Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1812 2
1869 1
1879 1
1884 1
1886 1
1911 1
1931 1
1944 1
1945 1
1947 1
1949 4
1950 2
1951 5
1952 4
1953 3
1954 7
1955 3
1956 4
1957 10
1958 5
1959 4
1960 8
1961 6
1962 5
1963 11
1964 14
1965 8
1966 15
1967 11
1968 10
1969 14
1970 19
1971 23
1972 24
1973 22
1974 24
1975 21
1976 28
1977 31
1978 46
1979 57
1980 39
1981 42
1982 50
1983 60
1984 45
1985 66
1986 52
1987 79
1988 69
1989 73
1990 88
1991 56
1992 95
1993 75
1994 105
1995 104
1996 97
1997 102
1998 110
1999 114
2000 113
2001 108
2002 141
2003 146
2004 139
2005 165
2006 204
2007 162
2008 205
2009 194
2010 211
2011 247
2012 242
2013 229
2014 252
2015 240
2016 259
2017 244
2018 250
2019 239
2020 267
2021 290
2022 285
2023 283
2024 186
2025 1

Text availability

Article attribute

Article type

Publication date

Search Results

6,660 results

Results by year

Filters applied: . Clear all
Page 1
Outpatient management of pediatric epistaxis: A cost analysis and clinical model.
Lee JA, Puchi C, Billings KR, Lavin JM, Hazkani I, Glennon C, Thompson DM, Maddalozzo J. Lee JA, et al. Among authors: thompson dm. Laryngoscope Investig Otolaryngol. 2024 Oct 8;9(5):e1310. doi: 10.1002/lio2.1310. eCollection 2024 Oct. Laryngoscope Investig Otolaryngol. 2024. PMID: 39380569 Free PMC article.
MYC-dependent upregulation of the de novo serine and glycine synthesis pathway is a targetable metabolic vulnerability in group 3 medulloblastoma.
Adiamah M, Poole B, Lindsey JC, Kohe S, Morcavallo A, Burté F, Hill RM, Blair H, Thompson D, Singh M, Swartz S, Crosier S, Zhang T, Maddocks ODK, Peet A, Chesler L, Hickson I, Maxwell RJ, Clifford SC. Adiamah M, et al. Among authors: thompson d. Neuro Oncol. 2024 Oct 8:noae179. doi: 10.1093/neuonc/noae179. Online ahead of print. Neuro Oncol. 2024. PMID: 39377369
Creation of de novo cryptic splicing for ALS and FTD precision medicine.
Wilkins OG, Chien MZYJ, Wlaschin JJ, Barattucci S, Harley P, Mattedi F, Mehta PR, Pisliakova M, Ryadnov E, Keuss MJ, Thompson D, Digby H, Knez L, Simkin RL, Diaz JA, Zanovello M, Brown AL, Darbey A, Karda R, Fisher EMC, Cunningham TJ, Le Pichon CE, Ule J, Fratta P. Wilkins OG, et al. Among authors: thompson d. Science. 2024 Oct 4;386(6717):61-69. doi: 10.1126/science.adk2539. Epub 2024 Oct 3. Science. 2024. PMID: 39361759
6,660 results